In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how clinical teams can boost participant retention in lengthy or complex trials through strategies like personalized engagement, stipends tied to ePRO diaries, and concierge services that offer one-to-one human connection.
In a recent video interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, discussed the challenges of retention and trial timelines due to increasing financial and logistical burdens on patients. Horville highlighted strategies to address these issues, such as early planning, patient advocacy, and site selection based on local needs. For complex trials, engagement through diary entries and stipends, and human interaction via concierge services will be critical. Future improvements will emphasize a comprehensive patient journey, incorporating services like travel prepayment to enhance trial success.
ACT: What are some best practices clinical operations professionals can adopt to improve participant retention across longer, complex trials?
Horville: Definitely, when we think of longer trials. First, in terms of length, there's a lot of time. We're hearing 10-15 year trials sometimes, so engagement for patients is going to be a really important factor to consider. How are we engaging with our patients? How are we motivating them to come back time and time again? We look at things like utilizing diary entries, ePRO, things to keep them engaged. At home, are we paying stipends when they complete their diaries each week to drive that retention, keeping them engaged? What we found to help with both longer and complex trials, both of those barriers, because they're different, is interaction with another human being and how important that is. We have something at Greenphire in terms of helping address that with our concierge services, that has a 95% retention rate, and that human interaction, that one to one relationship has been really, really impactful when we think of keeping them engaged. Really, that interaction with another human, that engagement and that motivation are going to be best practices there.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.